Robert Gundel

Robert Gundel

Geen lopende functies

Health Technology
Consumer Services

Profiel

Robert Gundel is the founder of Chatham Consulting Group, Inc. (founded in 2007).
He was the President, CEO & Non-Independent Director of ProMIS Neurosciences, Inc. from 2010 to 2015.
He held the position of Director-Pharmacology at Bayer Corp.
and Vice President-Pharmacology & Preclinical Research at Chiron Corp.
He was also the Chief Scientific Officer at Arius Research, Inc. in 2008 and Vice President-Research & Development at Elusys Therapeutics, Inc. in 2008.
In addition, he served as the Interim Chief Scientific & Technology Officer at Scorpius Holdings, Inc. in 2009 and Vice President-Scientific & Corporate Development at XOMA (US) LLC from 2005 to 2007.
Dr. Gundel holds an MBA from St. Mary's College of California and a doctorate from New York Medical College.

Eerdere bekende functies van Robert Gundel

BedrijvenFunctieEinde
PROMIS NEUROSCIENCES, INC. Algemeen Directeur 29-06-2015
SCORPIUS HOLDINGS, INC. Hoofd Techniek/Wetenschap/O&O 01-01-2009
Hoofd Techniek/Wetenschap/O&O 01-11-2008
Hoofd Techniek/Wetenschap/O&O 01-01-2008
Corporate Officer/Principal 01-01-2007
Ervaring van Robert Gundel in detail bekijken

Opleiding van Robert Gundel

St. Mary's College of California Masters Business Admin
New York Medical College Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Robert Gundel in detail bekijken

Connecties

25

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
SCORPIUS HOLDINGS, INC.

Health Technology

PROMIS NEUROSCIENCES, INC.

Health Technology

Bedrijven in privébezit6

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Chatham Consulting Group, Inc.

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Robert Gundel